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Evaluation of the nitric oxide production in rat renal artery
smooth muscle cells culture exposed to radiocontrast agents.
Background. Radiocontrast agents (RC), substances largely
used in diagnostic procedures, present the nephrotoxicity as
one of its major side effects, which could be due to an altered
synthesis of vasodilators. The aim of the present study was to
evaluate the nitric oxide (NO) production in rat renal artery
smooth muscle cells primary culture (rVSMC) exposed to RC.
Methods. The cells were treated for 72 hours with manni-
tol at 10% (MT10; 600 mOsm/kg H2O) or 35% (MT35; 2100
mOsm/kg H2O), with the nonionic iobitridol (IBT), the low-
osmolality ioxaglate (IXG), the high-osmolality ioxitalamate
(IXT), the nonionic, iso-osmolar iodixanol (IDX), and with
lipopolysaccharide (LPS). We determined the NO and osmo-
lality in the cell culture media and the cellular viability.
Results. By the Griess and chemiluminescence methods, the
NO was not different in MT10 and IDX, but decreased in
MT35, IBT, IXG, and IXT when compared with the control; it
was increased in LPS and also decreased in all RC+LPS when
compared with LPS. MT35, IXT, and IXT+LPS decreased the
cellular viability, and the media osmolality was increased in
MT35 and IXT compared with the control.
Conclusion. The RC (except IDX) significantly reduced NO
in rVSMC, which was more pronounced after IXT treatment
(57.3%). This was not related to the reduced cell viability
(15.8%) or to its high osmolality, because in MT35, with similar
osmolality as IXT, NO decreased only 11.0% relatively to the
control. Neither the media osmolality nor the cell viability was
altered by IXG or IBT. The decreased NO could explain the
vasoconstriction and, therefore, the acute renal failure by RC.
Radiocontrast agents (RC) are widely used for di-
agnostic procedures. They are iodized substances com-
pletely filtered at the glomeruli that are neither secreted
nor reabsorbed by the renal tubules. The use of RC is
relatively safe in individuals with normal renal function;
however, they can cause side effects of variable level, such
as hypotension, arrhythmias, cardiac insufficiency, vaso-
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constriction, thrombosis, and acute renal failure (ARF)
[1, 2]. The risk factors that may predispose patients to
ARF include diabetes mellitus, heart disease, advanced
age, dehydration, and pre-existing renal disease [1, 2].
Currently, three different types of RC are described: ionic
with high osmolality, ionic with reduced osmolality, and
nonionic RC; the latter were developed with aims to re-
duce the RC nephrotoxicity, but this effect is still a limit-
ing factor for their use.
The pathophysiology of RC-induced ARF is not yet
completely understood, but there is some evidence about
the role of vasoactive substances, which include adeno-
sine, endothelin, and nitric oxide (NO) [3]. According
to Andrade et al [4], diseases that affect the vascula-
ture, such as hypercholesterolemia, can predispose to
RC-induced ARF caused by NO decrease.
NO is a free radical gas, highly unstable, synthe-
sized from the amino acid L-arginine [5, 6]. Nitric ox-
ide synthase enzyme (NOS) catalyzes the conversion of
L-arginine to L-citrulline and NO [7]. This molecule has
a potent vasodilatory action [8], and its altered produc-
tion has been suggested in some cases of ARF caused
by drugs as gentamicin [9], glycerol [10], uranyl nitrate
[11], and also in renal tubule cell culture treated with a
nephrotoxic drug such as the cyclosporine A [12]. Owens
et al [13] observed a marked change in endothelial cell
culture viability as evaluated by cell lifting from the cul-
ture flasks, which was more accentuated with ionic when
compared with nonionic RC.
Agmon et al [14] observed that prostanoids, as well
as the NO, have an important protective role in a RC-
induced ARF model in rats.
In the present study we evaluated the NO production
in rat renal artery smooth muscle cells culture (rVSMC)
exposed to RC agents.
METHODS
Renal artery smooth muscle cell culture
Wistar male rats weighing 250 to 300 g were anaes-
thetized with a mixture of ketamine (80 mg/kg) and
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xylazine (10 mg/kg) by intraperitoneal injection [15]. The
kidneys were exposed through an abdominal incision
and the renal arteries were removed and washed in cold
phosphate-buffered saline (PBS). We used the “explant”
technique for smooth muscle cells primary culture.
The cells were grown in 25 cm2 culture flasks, in
Dulbecco’s modified Eagle’s medium (DMEM) with
NaHCO3 (2 g/L), HEPES (2.6 g/L), and penicillin (10,000
IU/L) supplemented with 20% fetal bovine serum (FBS)
and incubated in a humidified atmosphere with 5% CO2,
at 37◦C. After the first passage, DMEM with 10% FBS
was used.
The cells were used in the experiments between the
3rd and 10th passages. After semiconfluency was reached,
the medium was replaced by DMEM with 10% FBS and
with no-phenol red to avoid interference in the Griess
colorimetric method, and the cells were treated according
to the following groups.
Experimental groups
(1) Control (CTL): water was used as an RC vehicle
(10 lL/mL); (2) Mannitol (MT): used as an osmotic con-
trol (10 lL/mL), at 10% (MT10; 600 mOsm/kg H2O) or
35% (MT35; 2,100 mOsm/kg H2O). Lipopolysaccharide
of E. coli (LPS): used as a positive control of NO produc-
tion (100 lg/mL); (3) Ioxitalamate (IXT): high osmolal-
ity (2160 mOsm/kg H2O), ionic radiocontrast composed
of meglumin ioxitalamate + sodium ioxitalamate (4.6 ×
10−4 mol/L); (4) Ioxaglate (IXG): low osmolality
(695 mOsm/kg H2O), ionic radiocontrast composed of
meglumin ioxaglate + sodium ioxaglate (4.6 × 10−4 mol/
L); (5) Iobitridol (IBT): nonionic contrast of same osmo-
lality as IXG (4.6 × 10−4 mol/L); (6) (IXT, IXG or IBT) +
LPS groups.
A separate group of cells was treated either with water
(vehicle) or with iodixanol (IDX), a nonionic, iso-osmolar
(290 mOsm/kg H2O) RC (4.6 × 10−4 mol/L).
After 72 hours, the cell culture media were collected
and stored at −20◦C for NO determination. The cells
were then lysed with sodium dodecyl sulfate (SDS) 2%
and stored at −20◦C for protein determination.
Dose-response curve
A distinct group of cells was treated for 72 hours
with IXT, IXG, or IBT with the following doses: 1.38 ×
10−4 mol/L; 2.3 × 10−4 mol/L; 4.6 × 10−4 mol/L; 9.2 ×
10−4 mol/L, or 13.8 × 10−4 mol/L, and the dose-response
curve of NO synthesis was obtained through NO mea-
surement in the cell culture media.
Time-response curve
The supernatant from the cells treated with RC (4.6 ×
10−4 mol/L) during different periods of time (24, 48, or
72 hours) was collected, stored at −20◦C, and the NO
synthesis time-response curve was obtained.
NO determination
The NO was determined in the cell culture media by
the Griess colorimetric method [16] and by the chemilu-
minescence method [17].
Griess colorimetric method. Briefly, a v:v mix-
ture of sulfanilamide 1% (in H3PO4 5%) and naph-
thylethylenediamine 0.1% solution was added to the sam-
ples, and the absorbance at 546 nm was measured using
a GENESYS 2 spectrophotometer (Spectronic Instru-
ments, Inc., Rochester, NY, USA). The nitrite (NO2−),
one of the stable metabolites of NO, was then estimated
from a standard curve constructed using Na NO2.
Chemiluminescence method. We used the Model 280
Nitric Oxide Analyzer (NOATM) from Sievers Instru-
ments, Inc. (Boulder, CO, USA), a high-sensitive detector
for measuring nitric oxide, based on a gas-phase chemi-
luminescent reaction between NO and ozone:
NO + O3 → NO−2 + O2
NO−2 → NO2 + hv
The emission from electrically excited nitrogen dioxide is
in the red and near-infrared region of the spectrum, and
it is detected by a thermoelectrically cooled red-sensitive
photomultiplier tube. The sensitivity for measurement
of NO and its reaction products in liquid samples is
∼1 picomole.
Intracellular protein
Intracellular protein was measured by the Lowry
method [18] and used as a cell number correction fac-
tor in the correspondent culture flasks.
Osmolality
A separate group of cells from: CTL, MT10, MT35,
IXT, IXG, and IBT was treated as previously described,
the culture media was collected, and the osmolality was
measured by the freezing-point method [19] through the
Advanced Wide-Range Osmometer 3W2 (Advanced In-
struments, Norwood, MA, USA). The NO was also
measured in these groups using the chemiluminescence
method.
Cellular viability
Cellular viability in all experiments was assessed by the
exclusion of the fluorescent dyes acridine orange (AO)
and ethidium bromide (EB) [20]. After the cells were
trypsinized, a 10-lL sample of cell suspension was in-
cubated with 0.3 lL of AO/EB solution (100 lL/mL of
each dye). AO is cell permeable and binds to either the
double-stranded DNA to emit a green fluorescence (ex-
citation 502 nm, emission 525 nm), or single-stranded
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Table 1. NO synthesis (nmol/mg protein) and osmolality (mOsm/kg H2O) in cultured rVSMC
Control MT10 MT35 IXT IXG IBT
Griess 14.6 ± 0.7 14.3 ± 0.7 – 4.2 ± 0.5a 10.9 ± 1.2a,b 12.9 ± 0.6a,b,c
NO Analyzer 61.1 ± 2.0 61.4 ± 1.7 53.9 ± 0.9a 26.7 ± 1.4a 42.9 ± 1.1a,b 53.5 ± 1.8a,b,c
Osmolality 314 ± 5.5 320 ± 5.4 382 ± 4.3d 378 ± 5.1d 319 ± 3.4e 312 ± 5.2e
N = 10 for Griess and NO Analyzer, and N = 6 for osmolality and for NO in MT35. Values are mean ± SD. One-way analysis of variance (ANOVA) with Student–
Newman-Keuls post-test was used.
aP < 0.05 for NO vs. control.
bP < 0.05 for NO vs. IXT.
cP < 0.05 for NO vs. IXG.
dP < 0.05 for osmolality vs. control.
eP < 0.05 for osmolality vs. IXT.
Table 2. NO synthesis (nmol/mg protein) in cultured rVSMC
Control LPS IXT+LPS IXG+LPS IBT+LPS
Griess 14.6 ± 0.7 455.2 ± 2.3a 260.2 ± 2.7a,b 423.6 ± 2.2a,b,c 433.7 ± 1.4a,b,c,d
NO Analyzer 61.1 ± 2.0 2758.2 ± 2.5a 1877.4 ± 2.5a,b 2260.4 ± 1.3a,b,c 2448.9 ± 1.3a,b,c,d
N = 10 for all groups. Values are mean ± SD. One-way analysis of variance (ANOVA) with Student–Newman-Keuls post-test was used.
aP < 0.05 vs. control.
bP < 0.05 vs. LPS.
cP < 0.05 vs. IXT+LPS.
dP < 0.05 vs. IXG+LPS.
RNA to emit a reddish-orange fluorescence (excitation
460 nm, emission 650 nm). In contrast, EB binds only
to the double-stranded DNA and also emits a red fluo-
rescence (excitation 510 nm, emission 595 nm); however,
the cell is not permeable to the dye when the plasma
membrane is intact, and therefore, only necrotic cells will
take up this dye (with the red fluorescence quashing the
green/orange of AO). Cell suspensions were observed un-
der a fluorescent microscope at 40× magnification, and
200 cells were counted from a number of microscopic
fields. Cells emitting a green fluorescence were consid-
ered viable, and those emitting a red fluorescence were
considered nonviable. Viable cells were expressed as a
percentage of the total cells counted.
Statistical analysis
Results were expressed as mean ± SD. To compare the
NO between the groups we used the one-way analysis of
variance (ANOVA) with Student–Newman-Keuls post-
test. ANOVA with Student–Newman-Keuls post-test was
used for cellular viability and the cell media osmolality.
NO dose-response and time-response curves were an-
alyzed through Kruskal-Wallis with Student–Newman-
Keuls post-test. Statistical significance was defined as
P < 0.05.
Chemicals
Acridine orange, copper sulfate, DMEM, Folin,
HEPES, LPS (from E. coli serotype 0111:B4), NaK-
tartrate, naphthylethylenediamine, ortho-phosphoric
acid, ethidium bromide, PBS, penicillin, SDS, sodium
bicarbonate, sodium hydroxide, sodium nitrite, sul-
fanilamide, sodium nitrate, trypsin-EDTA solution,
and vanadium were purchased from Sigma Chemical
Company (St. Louis, MO, USA). FBS was obtained from
Gibco or Cultilab (Campinas, Brazil). Mannitol was
obtained from Ecibra (Sa˜o Paulo, Brazil), ketamine and
xylazine from Virbac (Sa˜o Paulo, Brazil). IXT (Telebrix
35), IXG (Hexabrix 320), and IBT (Henetix) were
obtained from Guerbet (Jacarepagua´, Brazil). IDX
(Visipaque 320) was obtained from Sanofi-Synthelabo
(Sa˜o Paulo, Brazil).
RESULTS
By the Griess method (all groups with N = 10; Tables 1
and 2) there was no statistical difference in NO synthe-
sis (NO2−, nmol/mg protein) between MT10 (14.3 ± 0.7)
when compared to CTL (14.6 ± 0.7). In the IXT, IXG,
and IBT groups the nitrite production was reduced when
compared to CTL (4.2 ± 0.5, 10.9 ± 1.2, 12.9 ± 0.6, re-
spectively; P < 0.05 for all groups). The NO reduction
caused by IXT was more pronounced when compared to
the IXG (P < 0.05) or to the IBT (P < 0.05), while the
reduction caused by IXG was more pronounced when
compared to IBT (P < 0.05). In the IDX group (N = 4),
the nitrite was not different from CTL (N = 3): 11.6 ±
1.3 versus 11.7 ± 2.0, respectively; P > 0.05.
In the LPS group, NO was increased (455.2 ± 2.3;
P < 0.05) when compared to CTL. The simultaneous
treatment with the RC attenuated the LPS effect, which
was, again, more remarkable in the IXT group (260.2 ±
2.7; P < 0.05), followed by the IXG (423.6 ± 2.2; P <
0.05) and the IBT (433.7 ± 1.4; P < 0.05).
In Tables 1 and 2 we also present the results ob-
tained by the chemiluminescence method (NO, nmol/mg
protein). The same pattern as determined by the Griess
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Fig. 1. Dose-response curve of nitric oxide (NO) synthesis in rat renal
artery smooth muscle cells primary culture (rVSMC) treated with iox-
italamate (IXT), ioxaglate (IXG), or iobitridol (IBT) analyzed by the
chemiluminescence method. N = 4 for all groups. Mean ± SD. ANOVA
with Student–Newman-Keuls post-test was used for statistical analysis:
for IXT, IXG, or IBT at 1.38 × 10−4 mol/L, P < 0.05 vs. CTL. For all
RC, P < 0.05 for each subsequent dose utilized. For all doses, P < 0.05:
IXG vs. IXT; IBT vs. IXT; and IBT vs. IXG.
method was observed for each group. The MT10 group
did not present any difference when compared to the CTL
(61.4 ± 1.7 vs. 61.1 ± 2.0, respectively; P > 0.05). In the
IXT group there was a decrease in NO production (26.7 ±
1.4, P < 0.05) when compared to the CTL. The same was
observed in the IXG and IBT groups (42.9 ± 1.1 and
53.5 ± 1.8, respectively; P < 0.05 vs. CTL), although this
reduction in the NO synthesis was less than in the IXT
group. In the cells treated with IDX (N = 4) the NO pro-
duction was not different from CTL (N = 3): 54.7 ± 8.6
vs. 58.9 ± 6.1, respectively; P > 0.05.
In the LPS group there was an increase in NO synthesis
when compared to the CTL (2758.2 ± 2.5; P < 0.05). The
RC used simultaneously with LPS provoked a decrease in
NO synthesis, which was more pronounced with the IXT
(1877.4 ± 2.5; P < 0.05), followed by the IXG (2260.4 ±
1.3; P < 0.05) and the IBT (2448.9 ± 1.3; P < 0.05) when
these groups were compared to the LPS group.
Figure 1 shows the dose-response curve of the NO syn-
thesis (nmol/mg protein), determined through the chemi-
luminescence method, in the rVSMC exposed to IXT,
IXG, or IBT. It was observed that even small doses of
RC (1.38 × 10−4 mol/L) are capable of inhibiting NO
synthesis significantly. This was observed for the three
different types of RC, and most of the NO synthesis
decrease occurred in the IXT group, at all the studied
doses: 1.38, 2.3, 4.6, 9.2, or 13.8 × 10−4 mol/L (42.9 ± 0.5,
34.6 ± 0.6, 27.0 ± 0.6, 23.4 ± 0.4, 20.6 ± 0.6, respectively;
N = 4), followed by the IXG (51.7 ± 0.8, 47.5 ± 1.2,
42.7 ± 0.4, 39.5 ± 0.2, 37.1 ± 1.4, respectively; N = 4) and
the IBT (56.2 ± 0.3, 54.8 ± 0.2, 52.7 ± 1.2, 51.1 ± 0.9,
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Fig. 2. Time-response curve of nitric oxide (NO) synthesis in rat re-
nal artery smooth muscle cells primary culture (rVSMC) (24-, 48-, or
72-hour treatment) treated with ioxitalamate (IXT), ioxaglate (IXG),
or iobitridol (IBT) (4.6 × 10−4 mol/L) and analyzed by the chemilu-
minescence method. N = 4 for all groups. Mean ± SD. ANOVA with
Student–Newman-Keuls post-test was used for statistical analysis: NO
synthesis significantly increased in all groups at each increase of time.
However, this increase in NO synthesis is significantly smaller in the
groups IXG and IXT when compared to the control (CTL).
48.2 ± 0.7, respectively; N = 4). All values were signifi-
cantly lower when compared to the CTL group (60.5 ±
2.7; N = 4).
Figure 2 shows the NO synthesis time-response curve
when the rVSMC were incubated with the RC during
24, 48, or 72 hours; NO (nmol/mg protein) was analyzed
by the chemiluminescence method. At any incubation
time analyzed, we observed a decrease in the NO syn-
thesis in the RC groups: IXT (25.4 ± 0.8, 26.6 ± 0.6,
26.2 ± 0.6, respectively; N = 4) and IXG (39.3 ± 0.4,
45.8 ± 6.6, 43.0 ± 0.5, respectively; N = 4), compared to
the CTL (50.5 ± 0.7, 52.7 ± 0.9, 59.4 ± 1.2, respectively;
N = 4). In the IBT group (50.6 ± 0.5, 52.6 ± 0.3, 54.4 ±
0.3, respectively; N = 4), only at 72 hours was there a
difference in NO production as compared to the CTL.
When the rVSMC were exposed to LPS, the NO synthesis
was significantly increased when compared to the CTL,
at the three points analyzed (773.6 ± 1.3, 2460.0 ± 1.5,
2750.3 ± 1.2, respectively; N = 4).
There was no difference in NO synthesis in the MT10
group (50.3 ± 1.1, 52.5 ± 0.6, 61.1 ± 1.9, respectively;
N = 4) when it was compared to the CTL.
Table 1 shows the results of osmolality (mOsm/kg
H2O) determined in the culture media of the cells treated
with MT or with the RC. A significant increase of the
osmolality was observed in the MT35 and IXT groups
(382 ± 4.3 and 378 ± 5.1, respectively; N = 6) when com-
pared to the CTL (314 ± 5.5, N = 6); the other groups
did not present any alteration when compared to the CTL
group: MT10 (320 ± 5.4, N = 6), IXG (319 ± 3.4, N = 6),
and IBT (312 ± 5.2, N = 6).
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The production of NO (nmol/mg protein) was also ana-
lyzed by the chemiluminescence method in these groups,
and presented an identical behavior described previously
in this study as follows: CTL group (60.6 ± 1.1, N =
6); MT10 did not present a significant alteration when
compared to the CTL (60.5 ± 1.2, N = 6); the groups
IXT, IXG, and IBT had the production of NO reduced
when compared to the CTL (25.9 ± 0.9, 42.9 ± 0.6, and
53.2 ± 1.0, respectively; N = 6), which was more remark-
able in the IXT group. In the MT35 group there was a sig-
nificant decrease in the NO production when compared
to the CTL (53.9 ± 0.9, N = 6), but this decrease was
significantly less than in the IXT group.
In Figures 3A and B we can observe that there was
no significant alteration in the cellular viability between
the groups CTL (96.4 ± 0.6%; N = 10), MT10 (96.2 ±
0.4%; N = 10), LPS (96.2 ± 0.3%; N = 10), IXG (95.8 ±
0.6%; N = 10), IBT (95.9 ± 0.6%; N = 10), IXG + LPS
(95.7 ± 0.6%; N = 10) and IBT + LPS (95.9 ± 0.3%;
N = 10). There was a significant decrease of the cellular
viability in the groups MT35 (81.4 ± 1.2%; N = 10), IXT
(81.2 ± 0.6%; N = 10), and IXT + LPS (80.9 ± 0.5%;
N = 10) when compared to the CTL.
DISCUSSION
The RC agents have the nephrotoxicity as a major lim-
iting factor, mainly in patients with previous renal disease
[1].
Some studies have showed that the RC enhances the
metabolic activity and oxygen consumption due to the os-
motic diuresis [21], increases the glomerular vascular re-
sistance, and decreases the glomerular filtration rate [22].
According to a meta-analysis study from 1985 to 1991, the
use of low-osmolality contrast media may be beneficial
in patients with pre-existing renal failure [23]. In spite of
these reports, at the moment there are not enough data
to confirm the importance of the high osmolality or other
factors on the pathogenesis of the nephrotoxicity caused
by the RC.
There are several evidences that the acute renal failure
caused by the RC seems to be a consequence of an im-
balance between vasoconstrictor factors like adenosine
[24, 25], endothelin [26], or angiotensin [24], and the va-
sodilator agents like the prostaglandins or NO [14].
In many studies the role of NO in the renal hemo-
dynamics regulation has been reported. Lahera et al
[27] suggested that the NO regulates the renal blood
flow (RBF) in meclofenamate-treated dogs, which pre-
sented significant increases in RBF and natriuresis af-
ter intrarenal infusion of acetylcholine. A decreased NO
synthesis, or a lack of response of the endothelium to va-
sodilators, has been suggested as possible mechanisms for
the ischemic [28] or the nephrotoxic ARF [9, 10, 11].
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Fig. 3. (A) Cellular viability. N = 10 for all groups. Mean ± SD.
Kruskal-Wallis with Student–Newman-Keuls post-test was used. ∗P <
0.05 vs. control (CTL). (B) Cellular viability. N = 10 for all groups. Mean
± SD. Kruskal-Wallis with Student–Newman-Keuls post-test was used.
∗P < 0.05 vs. lipopolysaccharide (LPS).
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We evaluated the NO production in cultured re-
nal artery smooth muscle cells after exposure to RC
agents.
As other studies have demonstrated the LPS capacity
to increase the NO synthesis, for example, in the glomeru-
lar mesangial cell culture [29] and in the rat aorta [30], we
utilized this drug as a positive control. As we expected,
when the rVSMC were exposed to the LPS at the same
dose used in the mesangial cell culture, there was a sig-
nificant increase in the NO production (Table 2).
In our study, the rVSMC treated with IXG presented
a significant decrease in the NO synthesis, measured by
the Griess or the chemiluminescence methods (Table 1).
The chemiluminescence is considered a more sensitive
method than the Griess assay, capable of detecting both
NO metabolites, the nitrite and the nitrate. Kanamuro
et al [31] observed that the Griess method is not ef-
fective in detecting small alterations in this molecule in
osteoblastic cell culture; however, in the present study, us-
ing rVSMC through this method we detected significant
changes in the NO synthesis, caused by the RC, although
all the values were lower than those measured by the
chemiluminescence.
The nonionic IBT also caused a significant reduction
of NO synthesis relatively to the CTL group, but this re-
duction was less intense than that provoked by the IXG
(Table 1). The IXT, considered the most nephrotoxic
among them, was capable of inhibiting the NO synthe-
sis with a greater intensity than the others.
Other groups suggested a relationship between the RC
and the NO reduction. Schwartz et al [32] observed that
the administration of RC to rats resulted in a signifi-
cant decrease in urinary guanosine 3′,5′-cyclic monophos-
phate, as well as NO2− + NO3− excretion, and this
decrease was significantly attenuated by L-arginine. Be-
sides, the RC caused a reduction in the RBF and the
GFR, which was attenuated by L-arginine; their results
suggest that NO plays a major role in the pathogenesis of
RC-induced ARF.
Heyman et al [33] observed that in the rat renal cor-
tex IXT might reduce the NOS activity, an effect blunted
by endothelin release. In another study, Furuta et al [34]
showed that IXG and iohexol (a nonionic RC) reduced
NO2− levels in human endothelial cell culture; this effect
on NO was associated to an increased endothelial cell
permeability, which was inhibited by sodium nitroprus-
side (SNP, an NO donor) and exacerbated by L-NMMA
(NG-monomethyl-L-arginine, an NO inhibitor).
In a recent article, Miller et al [35] have shown that
L-arginine does not prevent the RC nephrotoxicity in
human, which could discard the role of NO in this
physiopathology. However, in this study the percentage
of diabetic patients was higher in the L-arginine compared
to the placebo group (33% vs. 19%, respectively), and the
administration of a NO substrate could not be effective
because of the possible vascular lesions present in the di-
abetic patients. Besides, the authors did not consider the
patients’ body mass index, and they might require dif-
ferent amounts of L-arginine to prevent the decrease on
the creatinine clearance after the contrast media (CM)
exposure.
In a randomized, double-blind, and prospective mul-
ticenter study, including 129 patients with diabetes and
elevated serum creatinine, Aspelin et al [36] showed that
the iso-osmolar, nonionic IDX, did not induce significant
changes in the creatinine concentration, as did iohexol, a
low-osmolar nonionic CM. In our study, IDX caused no
effect on NO production, which could explain why this
RC caused no impairment on the renal function of those
patients.
When the LPS was used simultaneously with the RC
IXT, IXG, or IBT (Table 2), we observed an increased NO
synthesis; however, the values were lower than the LPS
group alone, showing the RC capacity to reduce NO syn-
thesis by the cells, even under the action of LPS, known
as a potent stimulator of the inducible isoform of the ni-
tric oxide synthase (iNOS). This partial blockade of NO
synthesis was more pronounced with the IXT than with
the IXG and with the IBT, observed by both the Griess
and the chemiluminescence methods (Table 2).
It has been reported by other investigators that the
RC can cause an increase in sodium load in the thick
ascending limb of Henle loop, resulting in an oxygen
consumption increase, and consequently, the release of
vasoconstrictive substances with afferent arteriole con-
striction [21]. This alteration, in addition to the reduction
of the potent vasodilator, the NO, could explain the re-
duced GFR and the ARF caused by the RC.
The reasons by which the GFR is decreased by the RC
are still unknown. There are some data suggesting that the
high osmolality of these substances can damage several
portions of the renal tubules [25].
In contrast with our data obtained with the rVSMC,
Agmon et al [14] observed that in the rat outer re-
nal medulla, the high-osmolality RC increases NO and
prostaglandins release. However, when the rats treated
with the RC received L-NAME, an NO synthesis in-
hibitor, there was a 50% necrosis of the thick ascending
limb of Henle.
Haller et al [37] showed that the radiocontrasts di-
atrizoate and iopamidol reduced cell viability both in
the pig kidney epithelial cell line (LLC-PK1) and Madin
Darby canine kidney (MDCK) cells, and it was more pro-
nounced with the use of ionic high-osmolality RC than
with the nonionic low-osmolality RC.
In the present study we used MT as an osmotic con-
trol because this drug, at the concentration of 10%, has
an osmolality similar to the RC IXG and IBT (about
600 mOsm/kg H2O). At this concentration the MT did
not alter the osmolality of the cell culture media when
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compared to the CTL. In the MT10 group we did not
observe any significant alteration in NO synthesis when
compared to CTL (Table 1).
However, when we used the mannitol at the concen-
tration of 35%, which has an osmolality similar to the
high-osmolality RC IXT (2100 mOsm/kg H2O), it caused
an increase in the cell culture media osmolality (21%)
similar to that caused by the IXT (20.3%) (Table 1). Be-
sides, there was observed a significant reduction in NO
production by MT35, but this decrease was still signifi-
cantly less when compared to the IXT. The NO produc-
tion in the group MT35 was 11.1% less than the CTL,
while in the IXT group this reduction was 57.3%. These
data suggest that the striking decrease in the NO produc-
tion caused by the IXT cannot be totally due to its high
osmolality.
In a recent study developed in the Nephrology Division
of Escola Paulista de Medicina, Leita˜o et al [38] showed
that the incubation of LLC-PK1 cells with an hyperos-
motic media protected against the injury and cellular
death caused by cisplatin, an antineoplasic drug, through
the stimulation of the heat shock proteins (HSP). If the
high osmolality can protect the cells through HSP, it is
unlikely that the osmolality of the contrast media IXT
could be responsible for the reduction of the cell viabil-
ity, and by this mechanism, be able to decrease the NO,
as observed in the present study.
A hypothesis to explain the NO reduction is the inhi-
bition of the tetrahydrobiopterin (BH4), a cofactor for
this molecule synthesis. Prabhakar [39] observed that in
cultured mesangial cells treated with high glucose, NO
was inhibited and this effect was reversed with both
L-arginine, substrate for NO synthesis, or with BH4
addition.
Interesting data from our study show that the cellu-
lar viability was reduced on a similar way on cells ex-
posed to IXT (15.8%) and to MT35 (15.6%), while the
other RC agents, IXG and IBT, did not cause any change
(Fig. 3A). The RC IXT significantly reduced the cellu-
lar viability when compared to the CTL group, while the
groups treated with the RC IXG and IBT presented vi-
ability similar to the CTL. Therefore, the NO reduction
caused by the RC IXG and IBT cannot be explained by a
cellular death. In the group IXT, the decreased NO syn-
thesis (57.3%) was disproportional to the cell viability
decrease observed in this group.
Therefore, the high reduction of the NO synthesis
caused by IXT is not, at least totally, related to the cellular
death observed after exposure to this substance, but per-
haps it is due to changes on NO production mechanism,
depleting some cofactor such as the BH4, or changing its
substrate, the L-arginine, or interfering with the NOS, for
example, through the nuclear factor kappa B (NFjB),
which inhibits the iNOS mRNA transcription and, con-
sequently, the NO synthesis [40].
CONCLUSION
In our study we observed that the three RC (IXT, IXG,
and IBT), caused a significant decrease in NO synthesis,
with a more pronounced effect caused by the IXT, the
most nephrotoxic RC among them. This phenomenon
would implicate a vasoconstriction, and it could be the
mediator of the renal function decrease, resulting in ARF.
IDX, the least nephrotoxic of the RC used in this study,
was not associated with any reduction in the NO synthe-
sis. The high osmolality of these substances has been re-
lated to the ARF caused by the RC; however, in this study,
mannitol at 35%, with a similar osmolality as IXT, caused
no changes in NO, disclosing, therefore, the increased os-
molality as a main factor in the pathophysiology of ARF
induced by RC.
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